Head-to-head · Value Score
CoreAge Rx vs Rejuve Meds
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Rejuve Meds a 75. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$149/mo
Save ~89% vs brand-nameRejuve Meds
#135 · Grade C+ · Fair Price
Est. first month
From $165/mo (starting dose, compounded)
Save ~88% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 75 — an est. $149/mo first month, with no teaser step-up baked in. Rejuve Meds isn't out of it: Shoppers wanting transparent, low-cost compounded GLP-1 with no membership fees and HSA/FSA eligibility.
CoreAge Rx is also our overall #1 pick across the whole deals board — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Rejuve Meds |
|---|---|---|
| Value Score | 93 (A+) | 75 (C+) |
| Est. first month | $149/mo | From $165/mo (starting dose, compounded) |
| Save vs brand-name | ~89% | ~88% |
| Semaglutide | $149/mo | From $165/mo (starting dose, compounded) |
| Tirzepatide | $349/mo | From $265/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Rejuve Meds
Rejuve Meds (Rejuve, Inc.) is a GLP-1 weight-loss telehealth service offering doctor-guided compounded semaglutide at $165/mo and dual-action compounded tirzepatide (GLP-1/GIP) at $265/mo, with no…
Why it's a deal
- Transparent published pricing: compounded semaglutide $165/mo, tirzepatide $265/mo
- No membership fees — everything is included; free shipping
- HSA/FSA eligible; intro pricing from $85 for the first month
- Doctor-guided programs with personalized care
- Names a "Rejuve Meds Pharmacy Network" for fulfillment
The fine print
- Individual compounding pharmacies not named (only a "pharmacy network")
- Prescribing medical group not named
- States of operation not published
- Not LegitScript-certified (no certification displayed)
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives board, and the same list for the other side is on alternatives to Rejuve Meds.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.